A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
Phase 4
Completed
- Conditions
- Photorefractive Keratectomy
- Interventions
- Other: ketorolac 0.4%
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT00330798
- Locations
- 🇺🇸
Lackland Air Force Base, San Antonio, Texas, United States
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- First Posted Date
- 2006-05-16
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 88
- Registration Number
- NCT00326092
- Locations
- 🇺🇸
Fort Worth and Other Sites, Fort Worth, Texas, United States
Anecortave Acetate in Patients With Open-angle Glaucoma
Phase 2
Completed
- Conditions
- Open-angle Glaucoma
- Interventions
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 86
- Registration Number
- NCT00320203
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
Phase 2
Completed
- Conditions
- Eye Diseases
- Interventions
- First Posted Date
- 2006-04-19
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 70
- Registration Number
- NCT00315640
- Locations
- 🇵🇷
Bayamon, Bayamon, Puerto Rico
🇭🇺Budapest, Budapest, Hungary
🇳🇱Amsterdam, Amsterdam, Netherlands
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 437
- Registration Number
- NCT00314171
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 523
- Registration Number
- NCT00314158
- Locations
- 🇺🇸
United States Investigative Sites, Fort Worth, Texas, United States
Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora
- First Posted Date
- 2006-04-10
- Last Posted Date
- 2012-11-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 137
- Registration Number
- NCT00312338
- Locations
- 🇺🇸
Multiple Locations, Fort Worth, Texas, United States
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Glaucoma, Open-angleOcular Hypertension
- Interventions
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 408
- Registration Number
- NCT00311389
- Locations
- 🇧🇪
European Facilitiies, Puurs, Belgium
Anecortave Acetate Risk-Reduction Trial (AART)
Phase 3
Terminated
- Conditions
- Dry AMD
- Interventions
- Other: Anecortave Acetate Vehicle
- First Posted Date
- 2006-03-28
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 2596
- Registration Number
- NCT00307398
- Locations
- 🇺🇸
Study Centers in the United States and Globally, Fort Worth, Texas, United States
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Primary Open Angle GlaucomaOcular Hypertension
- First Posted Date
- 2006-03-08
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 30
- Registration Number
- NCT00300079
© Copyright 2025. All Rights Reserved by MedPath